Gut Microbiota and Vascular Diseases: An Update
Cardiovascular Innovations and Applications · 2024 · 9 (1)
DOI: 10.15212/cvia.2023.0090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Innovations and Applications, 2024. Verfasst von Jiaqi Wu und 4 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Vascular diseases, including atherosclerosis, aneurysms, and vascular calcification, are a leading cause of morbidity and mortality worldwide. In past decades, the gut microbiota has been found to be an indispensable population exerting effects on hosts under physiological and pathological conditions. Gut microbiota-derived metabolites, such as trimethylamine-N-oxide and short-chain fatty acids, mediate these effects by regulating vascular cells systematically. Translation of research knowledge to clinical scenarios has led to the development of new therapies including dietary interventions and metabolite inhibitors. This review describes recent advancements in understanding of the interplay between the gut microbiota and vascular dysfunction, and potential treatments for vascular diseases.
Zitieren
APA
Wu, J., Li, Y., Yang, P., Fu, J., & Wang, Y. (2024). Gut Microbiota and Vascular Diseases: An Update. Cardiovascular Innovations and Applications, 9(1). https://doi.org/10.15212/cvia.2023.0090
Vancouver
Wu J, Li Y, Yang P, Fu J, Wang Y. Gut Microbiota and Vascular Diseases: An Update. Cardiovascular Innovations and Applications. 2024;9(1). doi:10.15212/cvia.2023.0090
BibTeX
@article{Wu2024,
author = {Wu, Jiaqi and Li, Yuxuan and Yang, Peipei and Fu, Jiantao and Wang, Yidong},
title = {Gut Microbiota and Vascular Diseases: An Update},
journal = {Cardiovascular Innovations and Applications},
year = {2024},
volume = {9},
number = {1},
doi = {10.15212/cvia.2023.0090}
}
EUVIMED